WebJun 4, 2024 · Below we present the annualized performance delivered by CYCN stock since 6-3-2024 (the date of the most recent insider purchase). The performance of the investment from the time CYCN insider buying occurred is the ultimate test of whether insiders were right about CYCN being a good buy. CYCN Insider Buying WebCyclerion Therapeutics ( NASDAQ: CYCN) is owned by 47.85% institutional shareholders, 25.89% Cyclerion Therapeutics insiders, and 26.26% retail investors. Slate Path Capital LP is the largest individual Cyclerion Therapeutics shareholder, owning 7.16M shares representing 16.44% of the company.
CYCN Insider Trading Activity Cyclerion Therapeutics Insider Buys …
WebUncover the latest insider trading activity for Cyclerion Therapeutics, Inc. (CYCN). Know which insiders are buying and selling along with top shareholders and ownership breakdown. ... Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months. WebDuring the last quarter, CYCN stock was purchased by institutional investors including: Virtu Financial LLC Simplex Trading LLC Within the last year, these company insiders have … can a cna work as a cma
Friday 11/13 Insider Buying Report: CYCN Nasdaq
WebJun 21, 2024 · Cyclerion Therapeutics (CYCN) is pinning its hopes on CNS therapy. With a small market cap, no clinical data due until YE21, yet significant insider buying, this … WebThe Haslams agreed to buy billionaire investor Marc Lasry's 25% stake in the Bucks in a deal that values the NBA franchise at $3.5 billion back in February, per a previous … WebMar 30, 2024 · The CEO & Director of Cyclerion Therapeutics, Inc. (NASDAQ:CYCN), Peter Hecht, Just Bought 309% More Shares finance.yahoo.com - May 9 at 1:26 PM: Friday … fish coy